Correlation Between Visa and Acasti Pharma
Can any of the company-specific risk be diversified away by investing in both Visa and Acasti Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Acasti Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Acasti Pharma, you can compare the effects of market volatilities on Visa and Acasti Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Acasti Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Acasti Pharma.
Diversification Opportunities for Visa and Acasti Pharma
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Visa and Acasti is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Acasti Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acasti Pharma and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Acasti Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acasti Pharma has no effect on the direction of Visa i.e., Visa and Acasti Pharma go up and down completely randomly.
Pair Corralation between Visa and Acasti Pharma
Taking into account the 90-day investment horizon Visa is expected to generate 2.67 times less return on investment than Acasti Pharma. But when comparing it to its historical volatility, Visa Class A is 4.24 times less risky than Acasti Pharma. It trades about 0.09 of its potential returns per unit of risk. Acasti Pharma is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 233.00 in Acasti Pharma on August 29, 2024 and sell it today you would earn a total of 104.00 from holding Acasti Pharma or generate 44.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 91.16% |
| Values | Daily Returns |
Visa Class A vs. Acasti Pharma
Performance |
| Timeline |
| Visa Class A |
| Acasti Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
Visa and Acasti Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and Acasti Pharma
The main advantage of trading using opposite Visa and Acasti Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Acasti Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acasti Pharma will offset losses from the drop in Acasti Pharma's long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
| Acasti Pharma vs. Tonix Pharmaceuticals Holding | Acasti Pharma vs. Jaguar Animal Health | Acasti Pharma vs. Ibio Inc | Acasti Pharma vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |